ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
SNAL
Snail, Inc. Class A Common Stock
There isn't enough reported data to score SNAL yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SNAL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
SNAL's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
SNAL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.4x | $2.28 | — |
| Cheap | 17x | $9.02 | +296% |
| Fair | 22x | $11.59 | +408% |
| Expensive | 32x | $16.62 | +629% |
Historical ranges are pointers, not guarantees.
SNAL's PE is 4.4x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SNAL Forward outlook
There aren't enough analyst estimates for SNAL to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
SNAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.52 | +$3.92 |
| Q2 2026 | -$1.28 | +$1.04 |
| Q1 2026 | -$3.12 | -1742% |
| Q4 2025 | -$3.70 | -1580% |
| Q3 2025 | -$3.40 | -910% |
| Q2 2025 | -$2.32 | -$2.11 |
| Q1 2025 | $0.19 | +$1.26 |
| Q4 2024 | $0.25 | +$1.48 |
SNAL has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over SNAL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
SNAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $33.1M | +139% |
| Q2 2026 | $19.7M | -11% |
| Q1 2026 | $27.3M | +36% |
| Q4 2025 | $25.1M | -4.2% |
| Q3 2025 | $13.8M | -39% |
| Q2 2025 | $22.2M | +2.7% |
| Q1 2025 | $20.1M | +42% |
| Q4 2024 | $26.2M | -8.2% |
SNAL's revenue is growing: $33M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +91 points |
| Q2 2026 | -14% | -5.3 points |
| Q1 2026 | 7.7% | +28 points |
| Q4 2025 | -6% | -18 points |
| Q3 2025 | -69% | -71 points |
| Q2 2025 | -8.2% | -21 points |
| Q1 2025 | -20% | -4.8 points |
| Q4 2024 | 12% | -1.3 points |
SNAL has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
SNAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.4M | -$175.1K |
| Q1 2026 | $10.2M | +$11.3M |
| Q4 2025 | -$5.3M | -$1.7M |
| Q3 2025 | $5.4M | +$10.4M |
| Q2 2025 | -$3.2M | -1638% |
| Q1 2025 | -$1.1M | -116% |
| Q4 2024 | -$3.6M | -132% |
| Q3 2024 | -$5M | -$3M |
SNAL has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SNAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.0x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | -28.0x | Net Cash |
| Q4 2022 | 1.4x | Healthy |
| Q3 2022 | 0.3x | Very low |
| Q2 2022 | 0.8x | Very low |
SNAL has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
SNAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.3 | Neutral |
| Stochastic | 11.7 | Oversold |
SNAL's weekly RSI is 42 (neutral) and its Stochastic is 12 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
SNAL PE vs Technology Sector
| Metric | SNAL | Sector median | Relative |
|---|---|---|---|
| PE | 4.4x | 28x | 84% below |
| PE % | 0 | 39 | 39 pts below |
SNAL is trading at 4.4x earnings, a 84% discount to the Technology sector's median of 28x, though its earnings don't support one.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
SNAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.23 | 2.2% above |
| 20 week MA | $3.10 | 26% below |
| 50 week MA | $3.42 | 33% below |
| 100 week MA | $4.97 | 54% below |
| 200 week MA | $5.55 | 59% below |
SNAL has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 59% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
SNAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $15.0 | $6.50 | -57% |
| 2023 | $6.50 | $6.05 | -6.9% |
| 2024 | $6.05 | $9.35 | +55% |
| 2025 | $9.35 | $4.58 | -51% |
| 2026 YTD | $4.58 | $2.28 | -50% |
SNAL has the edge over ASTS on returns for 2026, with the stronger performance.